WHO IRIS >
Headquarters >
Journal Articles >

Files in This Item:

File Description SizeFormat
Thumbnail
19_2_2005.pdf203.05 kBAdobe PDFView/Open
Title: Nataluzimab : marketing withdrawal pending evaluation
Issue Date: 2005
Relation: WHO drug information 2005 ; 19(2) : 123
URI: http://www.who.int/iris/handle/10665/73401
Appears in Collections:Journal Articles



Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.